Royal Bank of Canada
RDY icon

Royal Bank of Canada’s Dr. Reddy's Laboratories RDY Stock Holding History

Royal Bank of Canada’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138M Buy
9,984,082
+434,805
+5% +$6.05M 0.02% 532
2025
Q4 		$134M Sell
9,549,277
-612,938
-6% -$8.6M 0.02% 539
2025
Q3 		$142M Buy
10,162,215
+200,167
+2% +$2.88M 0.02% 541
2025
Q2 		$150M Buy
9,962,048
+911,249
+10% +$13M 0.03% 482
2025
Q1 		$119M Sell
9,050,799
-986,447
-10% -$13.6M 0.02% 497
2024
Q4 		$158M Buy
10,037,246
+61,831
+0.6% +$929K 0.03% 425
2024
Q3 		$159M Sell
9,975,415
-302,400
-3% -$4.87M 0.03% 425
2024
Q2 		$157M Sell
10,277,815
-543,910
-5% -$7.8M 0.04% 388
2024
Q1 		$159M Sell
10,821,725
-277,310
-2% -$4.05M 0.04% 373
2023
Q4 		$154M Buy
11,099,035
+362,455
+3% +$4.85M 0.04% 387
2023
Q3 		$144M Sell
10,736,580
-3,694,280
-26% -$50M 0.04% 373
2023
Q2 		$182M Sell
14,430,860
-195,420
-1% -$2.28M 0.05% 335
2023
Q1 		$167M Sell
14,626,280
-112,570
-0.8% -$1.22M 0.05% 334
2022
Q4 		$153M Sell
14,738,850
-566,800
-4% -$6.11M 0.04% 366
2022
Q3 		$160M Sell
15,305,650
-863,825
-5% -$9.2M 0.05% 312
2022
Q2 		$179M Sell
16,169,475
-637,935
-4% -$6.94M 0.05% 295
2022
Q1 		$187M Sell
16,807,410
-281,665
-2% -$3.19M 0.05% 315
2021
Q4 		$224M Buy
17,089,075
+302,240
+2% +$3.81M 0.05% 305
2021
Q3 		$219M Buy
16,786,835
+119,295
+0.7% +$1.59M 0.06% 280
2021
Q2 		$245M Sell
16,667,540
-234,320
-1% -$3.28M 0.07% 260
2021
Q1 		$208M Sell
16,901,860
-203,420
-1% -$2.61M 0.06% 273
2020
Q4 		$244M Sell
17,105,280
-731,890
-4% -$9.86M 0.07% 244
2020
Q3 		$248M Sell
17,837,170
-441,510
-2% -$5.26M 0.09% 204
2020
Q2 		$194M Sell
18,278,680
-716,350
-4% -$7.29M 0.08% 217
2020
Q1 		$153M Sell
18,995,030
-1,734,090
-8% -$14.5M 0.07% 226
2019
Q4 		$168M Sell
20,729,120
-1,003,105
-5% -$7.92M 0.06% 275
2019
Q3 		$165M Sell
21,732,225
-622,415
-3% -$4.63M 0.07% 253
2019
Q2 		$168M Buy
22,354,640
+182,895
+0.8% +$1.44M 0.07% 245
2019
Q1 		$180M Sell
22,171,745
-234,050
-1% -$1.78M 0.08% 229
2018
Q4 		$169M Buy
22,405,795
+1,501,685
+7% +$10.6M 0.08% 210
2018
Q3 		$141M Buy
20,904,110
+99,500
+0.5% +$665K 0.06% 270
2018
Q2 		$134M Buy
20,804,610
+498,820
+2% +$3.15M 0.06% 265
2018
Q1 		$133M Sell
20,305,790
-1,636,525
-7% -$11.5M 0.06% 274
2017
Q4 		$165M Buy
21,942,315
+3,872,750
+21% +$27.9M 0.07% 230
2017
Q3 		$129M Buy
18,069,565
+766,500
+4% +$5.51M 0.06% 263
2017
Q2 		$146M Buy
17,303,065
+4,465,690
+35% +$36.3M 0.08% 223
2017
Q1 		$103M Buy
12,837,375
+204,095
+2% +$1.76M 0.06% 273
2016
Q4 		$114M Buy
12,633,280
+1,166,835
+10% +$10.9M 0.06% 264
2016
Q3 		$106M Buy
11,466,445
+1,073,425
+10% +$10.2M 0.06% 268
2016
Q2 		$106M Buy
10,393,020
+1,117,655
+12% +$10.2M 0.06% 244
2016
Q1 		$83.8M Buy
9,275,365
+6,253,140
+207% +$55.9M 0.05% 294
2015
Q4 		$28M Buy
3,022,225
+2,971,075
+5,809% +$32.5M 0.02% 734
2015
Q3 		$654K Sell
51,150
-2,100
-4% -$26.1K ﹤0.01% 3245
2015
Q2 		$590K Buy
53,250
+16,405
+45% +$181K ﹤0.01% 3456
2015
Q1 		$421K Sell
36,845
-134,025
-78% -$1.42M ﹤0.01% 3675
2014
Q4 		$1.72M Buy
170,870
+50,700
+42% +$534K ﹤0.01% 2455
2014
Q3 		$1.26M Buy
120,170
+7,200
+6% +$67.7K ﹤0.01% 2661
2014
Q2 		$976K Buy
112,970
+16,245
+17% +$137K ﹤0.01% 2860
2014
Q1 		$850K Buy
96,725
+34,310
+55% +$298K ﹤0.01% 2909
2013
Q4 		$512K Buy
62,415
+48,825
+359% +$386K ﹤0.01% 3397
2013
Q3 		$103K Sell
13,590
-48,515
-78% -$353K ﹤0.01% 4460
2013
Q2 		$470K Buy
+62,105
New +$453K ﹤0.01% 3218

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's RDY Position: Q1 2026 in Review

Royal Bank of Canada increased its Dr. Reddy's Laboratories (RDY) stake by 4.6% in Q1 2026, buying an estimated $6.05M and bringing the position to 9,984,082 shares worth $138M. The position accounts for 0.02% of the portfolio, ranked #532.

Royal Bank of Canada first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $248M in Q3 2020. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Royal Bank of Canada held 9,984,082 shares of Dr. Reddy's Laboratories worth $138M as of Q1 2026.
  • Royal Bank of Canada bought 434,805 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $6.05M.
  • Dr. Reddy's Laboratories made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #532 holding.
  • Royal Bank of Canada first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Dr. Reddy's Laboratories position peaked at $248M in Q3 2020.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.